Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
boston blog main
boston top stories
drugs
2
×
inotersen
life sciences
national blog main
national top stories
new york blog main
new york top stories
onpattro
patisiran
pfizer
2
×
san diego blog main
san diego top stories
tafamidis
alnylam pharmaceuticals
anylam pharmaceuticals
boston
cardiomyopathy
clinical trials
european medicines agency
fda
harvard pilgrim health care
hereditary transthyretin amyloidosis
institute for clinical and economic review
neuropathy
new york
tegsedi
transthyretin amyloidosis
What
alnylam
2
×
drug
fda
ago
akcea
amyloidosis
approved
approves
attr
available
battle
cells
debilitating
disease
ema
employ
europe
follows
gene
genetic
harmful
hits
interference
make
medicine
medicines
method
mute
oks
patients
pfizer
protein
rare
rna
rnai
sets
transthyretin
uses
way
year
Language
Current search:
alnylam
×
drugs
×
pfizer
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug